Diffuse large B-cell<unk> s of the stomach are primarily treated with chemotherapy with CHOP (cyclophosphamide+doxorubicine+vincristine+prednisone) with or without rituximab being a usual first choice. Antibiotic treatment to eradicate H. pylori is indicated as first line therapy for MALT<unk> s. About 80% of MALT<unk> s completely regress with eradication therapy. Radiation treatment for H. pylori negative gastric malt<unk> , has a high success rate, 90% or better after 5 years. Second line therapy for MALT<unk> s is usually chemotherapy with a single agent, and complete response rates of greater than 70% have been reported. Subtotal gastrectomy, with post-operative chemotherapy is undertaken in refractory cases, or in the setting of complications, including gastric outlet obstruction.
Gastric lymphoma
Poorly cohesive gastric carcinoma
Atrophic gastritis
Lymphocytic esophagitis
Oesophagogastric junctional adenocarcinoma
Hereditary diffuse gastric cancer
Tropical ulcer
Herpes esophagitis